These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16142349

  • 1. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J, Pavlová S, Svitáková M, Grochová D, Ravcuková B.
    Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
    [Abstract] [Full Text] [Related]

  • 2. High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast.
    Pavlova S, Mayer J, Koukalova H, Smardova J.
    Int J Oncol; 2003 Jul; 23(1):121-31. PubMed ID: 12792784
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
    Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL, Koeffler HP.
    Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, Wada K, Nishisaki H, Konda Y, Nagao M.
    Cancer Res; 1992 Aug 15; 52(16):4335-41. PubMed ID: 1322785
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors.
    Smardová J.
    Neoplasma; 1999 Aug 15; 46(2):80-8. PubMed ID: 10466430
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of a transcriptionally inactive p53 mutant by functional analysis of separated alleles in yeasts (FASAY) in a child osteosarcoma tumor: a case report.
    Dekairelle AF, Brichard B, Delhez H, Gala JL.
    Pediatr Hematol Oncol; 2004 Jun 15; 21(4):321-8. PubMed ID: 15205094
    [Abstract] [Full Text] [Related]

  • 14. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
    Liu Y, Bodmer WF.
    Proc Natl Acad Sci U S A; 2006 Jan 24; 103(4):976-81. PubMed ID: 16418264
    [Abstract] [Full Text] [Related]

  • 15. Functional analysis of p53 tumor suppressor in yeast.
    Smardová J, Smarda J, Koptíková J.
    Differentiation; 2005 Jul 24; 73(6):261-77. PubMed ID: 16138827
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL, Yoshizato K, Kluwe L, Meissner H, Warnecke G, Zapf S, Westphal M, Deppert W, Giese A.
    Anticancer Res; 2005 Jul 24; 25(1A):213-24. PubMed ID: 15816541
    [Abstract] [Full Text] [Related]

  • 18. Screen p53 mutations in hepatocellular carcinoma by FASAY: a novel splicing mutation.
    Wu XM, Fu JG, Ge WZ, Zhu JY, Wang JY, Zhang W, Qian W, Huo KK.
    J Zhejiang Univ Sci B; 2007 Feb 24; 8(2):81-7. PubMed ID: 17266182
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of p53 mutations in urothelial carcinoma by IHC and FASAY.
    Watanabe J, Nishiyama H, Okubo K, Takahashi T, Toda Y, Habuchi T, Kakehi Y, Tada M, Ogawa O.
    Urology; 2004 May 24; 63(5):989-93. PubMed ID: 15135005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.